DAWN2: Addressing emotional distress may improve diabetes self management

ORLANDO – Emotional distress associated with a diabetes diagnosis explains many patients’ difficulties with self-management, based on results from the DAWN2 study presented at the annual meeting of…

…read more

We suggest you read  Sarepta Therapeutics reports non-GAAP net loss of $29.1 million for Q4 2013